Multi-modal Liver Segmentation and Fibrosis Staging Using Real-world MRI Images
Authors
Abstract
Liver fibrosis represents the accumulation of excessive extracellular matrix caused by sustained hepatic injury. It disrupts normal lobular architecture and function, increasing the chances of cirrhosis and liver failure. Precise staging of fibrosis for early diagnosis and intervention is often invasive, which carries risks and complications. To address this challenge, recent advances in artificial intelligence-based liver segmentation and fibrosis staging offer a non-invasive alternative. As a result, the CARE 2025 Challenge aimed for automated methods to quantify and analyse liver fibrosis in real-world scenarios, using multi-centre, multi-modal, and multi-phase MRI data. This challenge included tasks of precise liver segmentation (LiSeg) and fibrosis staging (LiFS). In this study, we developed an automated pipeline for both tasks across all the provided MRI modalities. This pipeline integrates pseudo-labelling based on multi-modal co-registration, liver segmentation using deep neural networks, and liver fibrosis staging based on shape, textural, appearance, and directional (STAD) features derived from segmentation masks and MRI images. By solely using the released data with limited annotations, our proposed pipeline demonstrated excellent generalisability for all MRI modalities, achieving top-tier performance across all competition subtasks. This approach provides a rapid and reproducible framework for quantitative MRI-based liver fibrosis assessment, supporting early diagnosis and clinical decision-making. Code is available at https://github.com/YangForever/care2025_liver_biodreamer.